Pharmacotherapy of pulmonary embolism

References

• Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur. Heart J. (2000) 21:1301–1336.
   PubMedGoogle Scholar
• •Guidelines of the Europen Society of Cardiology.
   Google Scholar
• GOLDHABER SZ, VISANI L, DE ROSA M: Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet (1999) 353(9162):1386–1389.
   PubMed Web of Science ®Google Scholar
• •Pivotal International Registry of epidemiologic distribution of PE.
   Google Scholar
• LILIENFELD DE, CHAN E, EHLAND J, GODBOLD JH, LANDRIGAN PJ, MARSH G: Mortality from pulmonary embolism in the United States: 1962 to 1984. Chest (1990) 98:1067–1072.
   PubMed Web of Science ®Google Scholar
• GOLDHABER SZ: Echocardiography in the management of pulmonary embolism. Ann. Intern. Med. (2002) 136:691–700.
   PubMed Web of Science ®Google Scholar
• •Editorial on the use of echocardiography in the diagnosis of PE.
   Google Scholar
• KASPER W, KONSTANTINIDES S, GEIBEL A, TIEDE N, KRAUSE T, JUST H: Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart (1997) 77:346–349.
   PubMed Web of Science ®Google Scholar
• RIBEIRO A, LINDMARKER P, JUHLIN-DANNFELT A, JOHNSSON H, JORFELDT L: Echocardiographic doppler in pulmonary embolism: right ventricular dysfunction as predictor of mortality. Am. Heart J. (1997) 134:479–487.
   PubMed Web of Science ®Google Scholar
• CHARTIER L, BERA J, DELOMEZ M et al.: Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation (1999) 99:2779–2783.
   PubMed Web of Science ®Google Scholar
• KONSTANTINIDES S, GEIBEL A, KASPER W, OLSCHEWSKI M, BLUMEL L, JUST H: Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation (1998) 97:1946–1951.
   PubMed Web of Science ®Google Scholar
• MATTIOLI AV, CASTELLI A, MATTIOLI G: Relationship between mean right atrial pressure and doppler parameters in patients with right ventricular infarction. Clin. Cardiol (2000) 23:771–775.
   PubMedGoogle Scholar
• MATTIOLI AV, TARABINI CASTELLANI E: Pulmonary embolism of cardiac origin. Proceedings of the International Meeting of Internal Medicine. Catania, Italy (1993):56–58.
   Google Scholar
• ROSS R: Mechanisms of disease: atherosclerosis - an inflammatory disease. N. Engl. J. Med. (1999) 340:115–126.
   PubMed Web of Science ®Google Scholar
• HIRSH J, RASCHKE R, WARKENTIN TE, DALEN JE, DEYKIN D, POLLER J: Heparin: mechanism of action, pharmacokineties, dosing considerations, monitoring efficacy, and safety. Chest (1995) 108:258S–275S.
   Google Scholar
• BRANDJES DPM, HEIJBOER H, BULLER HR, DE RIJK M, JAGT H, TEN CATE JW: Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal vein thrombosis. N Engl. J. Med. (1992) 327:1485–1489.
   PubMedGoogle Scholar
• EGERMAYER P: Value of anticoagulants inthe treatment of pulmonary embolism: a discussion paper.' R. Soc. Med. (1981) 74:675–681.
   PubMedGoogle Scholar
• DALEN JE, BANAS JS Jr, BROOKS HL, EVANS GL, PARASKOS JA, DEXTER L: Resolution rate of acute pulmonary embolism in man. N Engl. I. Med. (1969) 280:1194–1199.
   PubMed Web of Science ®Google Scholar
• TOW DE, WAGNER NH Jr: Recovery of pulmonary arterial blood flow in patients with pulmonary embolism. N Engl. I. Med. (1967) 276:1053–1059.
   PubMed Web of Science ®Google Scholar
• MATTIOLI AV, BONETTI L, STERNIERI S, MATTIOLI G: Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up. Ital. Heart 1 (2000) 1(1):39–42.
   Google Scholar
• MATTIOLI AV, FONTANESI L, BONETTI L, VANDELLI R, MATTIOLI G: Heparin/PF4 complex antibodies in patients with unstable angina: evaluation of cardiac thrombotic events in 24 months of follow-up. Proceeding of Scientific Session of American College of Cardiology Atlanta, USA (2002):97A.
   Google Scholar
• WARKENTIN TE, CHONG BH, GREINNACHER A: Heparin-induced thrombocytopenia: toward consensus. Thromb. Haemost. (1998) 79:1–7.
   PubMed Web of Science ®Google Scholar
• BRIEGER DB, MAK KH, KOTTKE-MARCHANT K, TOPOL EJ: Heparin-induced thrombocytopenia. Am. Coll. Cardiol (1998) 31:1449–1459.
   PubMed Web of Science ®Google Scholar
• MONREAL M, RUIZ J, SALVADOR R, MORERA J, ARIAS A: Recurrent pulmonary embolism: a prospective study. Chest (1989) 95:976–979.
   PubMed Web of Science ®Google Scholar
• GOLDAHBER SZ: Recent advances in the diagnosis and lytic therapy of pulmonary embolism. Chest (1991) 99M:1735–1795.
   Google Scholar
• THE UROKINASE PULMONARY EMBOLISM TRIAL: A national cooperative study. Circulation (1973) 47(Suppl. II):1–108.
   Google Scholar
• •International randomised double blind trial on efficiency of urokinase.
   Google Scholar
• DOUKETIS JD, KEARON C, BATES S, DUKU EK, GINSBERG JS: Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. "AMA (1998) 279(6):458–462.
   PubMed Web of Science ®Google Scholar
• Low molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. New Engl. .1. Med. (1997) 337:657–662.
   PubMedGoogle Scholar
• •Randomised trial on the efficacy and safety of reviparin sodium.
   Google Scholar
• SIMONNEAU G, SORS H, CHARBONNIER B et al: A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. New Engl J. Med. (1997) 337:663–669.
   Google Scholar
• AGUILAR OM, KLEIMAN NS: Low molecular weight heparins. Expert Opin. Pharmacother. (2000) 1(6):1091–1193.
   PubMedGoogle Scholar
• ANDERSON JL: Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent. I. Am. Coll. Cardiol (1987) 10:22B–27B
   Google Scholar
• RIJKEN DC, COLLEN DC: Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J. Biol Chem. (1981) 256:7035–7041.
   PubMed Web of Science ®Google Scholar
• AGNELLI G: Rationale for bolus t-PA therapy to improve efficacy and safety. Chest (1990) 97:161S–176S.
   Google Scholar
• GOLDAHBER SZ: Thrombolysis in pulmonary embolism, a large-scale clinical trial is overdue. Circulation (2001) 104:2876–2878.
   PubMedGoogle Scholar
• MATTIOLI AV: Thrombolytic therapy in pulmonary embolism. Cardiologia (1991) 36(12):187–193.
   PubMedGoogle Scholar
• SAUTTER RD, EMANUEL DA, FLETCHER FW, WENZEL FJ, MATSON JI: Urokinase for the treatment of acute pulmonary thromboembolism. "AMA (1967) 202:295–298
   Google Scholar
• TOW DE, WAGNER HN, HOLMES RA: Urokinase in pulmonary embolism. N. Engl. J. Med. (1967) 277:1161.
   PubMed Web of Science ®Google Scholar
• Urokinase-Streptokinase Embolism Trial. Phase II results. A cooperative study. "AMA (1974) 229:1606–1613.
   Google Scholar
• SHIFFMAN F, DUCAS J, HOLLETT P, et al.: Treatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator. Efficacy of dosing regimes. Circulation (1988) 78(1):214–220.
   Google Scholar
• GOLDHABER SZ, VAUGHAN DE, MARKIS JE et al.: Acute pulmonary embolism treated with tissue plasminogen activator. Lancet (1986) 2:886–889.
   PubMed Web of Science ®Google Scholar
• GOLDHABER SZ, KESSLER CM, HEIT J et al.: A randomized control trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet (1988) 2:293–298.
   PubMed Web of Science ®Google Scholar
• GOLDHABER SZ, KESSLER CM, HEIT JA et al: Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. I. Am. Coll. Cardiol (1992) 20:24–30.
   PubMed Web of Science ®Google Scholar
• GOLDHABER SZ, HAIRE WD, FELDSTEIN ML et al: Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion. Lancet (1993) 341:507–511.
   PubMed Web of Science ®Google Scholar
• DALLA VOLTA S, PALLA A, SANTOLICANTRO A et al: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicenter Study 2.1 Am. Coll. Cardiol (1992) 20:520–526.
   PubMedGoogle Scholar
• GOLDHABER SZ, AGNELLI G, LEVINE MN et al.: Reduced dose bolus alteplase versus conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. Chest (1994) 106:718–724.
   PubMed Web of Science ®Google Scholar
• AGNELLI G, PARISE P: Bolus thrombolysis in venous thromboembolism. Chest (1992) 101:172S–182S.
   Google Scholar
• AGNELLI G, IORIO A, PARISE P et al.:Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. Blood Cava]. Fibrinolysis (1997) 8:216–222.
   PubMedGoogle Scholar
• SORS H, PACOURET G, AZARIAN R, MEYER G, CHARBONNIER B, SIMONNEAU G: Hemodynamic effects of bolus versus 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest (1994) 106(3):712–717.
   PubMedGoogle Scholar
• JERJES-SANCHEZ C, RAMIREZ-RIVERA A, GARCIA M DE L: Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. I. Thrombosis Thrombolysis (1995) 2:227–229.
   PubMedGoogle Scholar
• LEDERER W, LICHTENBERGER C, PECHLANER C, KROESEN G, BAUBIN M: Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation (2001) 50:71–76.
   PubMedGoogle Scholar
• RUIZ-BAILEN M, AGUAYO-DE-HOYOS E, SERRANO-CORCOLES MC: Thrombolysis with recombinant tissue plasminogen activator during cardiopulmonary resuscitation in fulminant pulmonary embolism. A case series. Resuscitation (2001) 51:97–101.
   PubMedGoogle Scholar
• KASPER W, KONSTANTINIDES S, GEIBEL A et al.: Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. I Am. Coll. Cardiol (1997) 30:1165–1171.
   PubMed Web of Science ®Google Scholar